Applied Therapeutics, Inc. logo

Applied Therapeutics, Inc.

NASDAQ:APLT

Overview | Financials
Company Name Applied Therapeutics, Inc.
Symbol APLT
Currency USD
Price 5.7
Market Cap 654,622,200
Dividend Yield 0%
52-week-range 1.5 - 9.39
Industry Biotechnology
Sector Healthcare
CEO Dr. Shoshana Shendelman Ph.D.
Website https://www.appliedtherapeutics.com

An error occurred while fetching data.

About Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment

Related Stocks

Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc.

MBRX

2.4 USD

Evogene Ltd. logo

Evogene Ltd.

EVGN

2.96 USD

Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc.

COCP

1.7 USD

AVROBIO, Inc. logo

AVROBIO, Inc.

AVRO

1.4 USD

Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc.

TPST

1.24 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

7.81 USD

Financials

Numbers are in millions USD

Numbers are in millions USD